Validation Study of NOVEOS® System (HYCOR)

TerminatedOBSERVATIONAL
Enrollment

536

Participants

Timeline

Start Date

December 4, 2019

Primary Completion Date

March 10, 2020

Study Completion Date

March 10, 2020

Conditions
Allergen-mediated IgE Allergy
Interventions
DEVICE

NOVEOS® system

"The NOVEOS® System is a fully automated, high-throughput immunoassay platform that uses magnetic microbeads as a solid phase.~This is a partially closed system that is primarily intended for the determination of specific IgE with NOVEOS® Hycor allergens. It has the CE mark."

Trial Locations (1)

34295

University Hospital of Montpellier, Montpellier

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hycor Biomedical

INDUSTRY

lead

University Hospital, Montpellier

OTHER